We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.35B
AUM Growth
+$61.6M
Cap. Flow
-$6.39M
Cap. Flow %
-0.19%
Top 10 Hldgs %
14.63%
Holding
1,352
New
104
Increased
455
Reduced
536
Closed
129

Sector Composition

Rank Sector Weight
1 Healthcare 14.91%
2 Financials 10.04%
3 Industrials 9.49%
4 Technology 9.43%
5 Consumer Discretionary 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HASI icon
451
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.85B
$1.49M 0.04%
68,797
+42,219
+159% +$848K
IVZ icon
452
Invesco
IVZ
$13B
$1.48M 0.04%
57,998
+17,991
+45% +$534K
SPLV icon
453
Invesco S&P 500 Low Volatility ETF
SPLV
$7.13B
$1.48M 0.04%
34,629
-49,319
-59% -$2M
WPXP
454
DELISTED
WPX Energy, Inc.
WPXP
$1.48M 0.04%
31,999
-6,600
-17% -$297K
XLY icon
455
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
$1.48M 0.04%
37,776
-12,242
-24% -$482K
FXO icon
456
First Trust Financials AlphaDEX Fund
FXO
$1.14B
$1.47M 0.04%
63,750
-18,133
-22% -$420K
GNTX icon
457
Gentex
GNTX
$5.03B
$1.47M 0.04%
94,924
+27
+0% +$429
HSY icon
458
Hershey
HSY
$35.9B
$1.46M 0.04%
12,822
-97
-0.8% -$9.08K
EEFT icon
459
Euronet Worldwide
EEFT
$2.92B
$1.45M 0.04%
21,008
LNKD
460
DELISTED
LinkedIn Corporation
LNKD
$1.45M 0.04%
7,660
-2,889
-27% -$400K
BNY
461
Bank of New York Mellon
BNY
$106B
$1.45M 0.04%
37,302
-121
-0.3% -$4.81K
PARA
462
DELISTED
Paramount Global Class B
PARA
$1.43M 0.04%
26,298
-2,886
-10% -$157K
XBI icon
463
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$1.43M 0.04%
26,463
+8,135
+44% +$446K
LUMN icon
464
Lumen
LUMN
$6.76B
$1.43M 0.04%
49,292
+3,979
+9% +$116K
VB icon
465
Vanguard Morningstar Small-Cap ETF
VB
$79.6B
$1.43M 0.04%
12,325
-531
-4% -$60.3K
OLN icon
466
Olin
OLN
$2.53B
$1.42M 0.04%
57,179
-13,233
-19% -$285K
GLF
467
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
$1.39M 0.04%
443,248
-10,282
-2% -$46.9K
TCO
468
DELISTED
Taubman Centers Inc.
TCO
$1.39M 0.04%
18,684
-250
-1% -$17.6K
VIG icon
469
Vanguard Dividend Appreciation ETF
VIG
$112B
$1.38M 0.04%
16,600
+2,371
+17% +$194K
KRE icon
470
State Street SPDR S&P Regional Banking ETF
KRE
$4.49B
$1.38M 0.04%
35,851
-4,978
-12% -$197K
IWN icon
471
iShares Russell 2000 Value ETF
IWN
$14.4B
$1.36M 0.04%
13,987
-6,964
-33% -$663K
CCOI icon
472
Cogent Communications
CCOI
$663M
$1.36M 0.04%
33,874
+150
+0.4% +$5.89K
WPZ
473
DELISTED
Williams Partners L.P.
WPZ
$1.36M 0.04%
39,156
+21,776
+125% +$645K
HBI
474
DELISTED
Hanesbrands
HBI
$1.35M 0.04%
53,867
+20,094
+59% +$548K
FTNT icon
475
Fortinet
FTNT
$113B
$1.35M 0.04%
213,335
-9,335
-4% -$60.4K

Similar funds

Oppenheimer & Co's Q2 2016 Portfolio in Review

As of Q2 2016, Oppenheimer & Co held 1,352 positions worth $3.35B, up 1.9% from $3.29B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer & Co's Q2 2016 filing shows 104 new, 455 increased, 536 reduced and 129 closed positions. Its largest new stake was WisdomTree India Earnings Fund ETF: 201,376 shares worth $4.07M. The largest sale was Energy Transfer Partners L.p., an estimated $6.24M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q2 2016 buy was WisdomTree India Earnings Fund ETF: 201,376 shares worth $4.07M.
  • Oppenheimer & Co added most to Foundation Medicine, Inc. in Q2 2016, an estimated $4.54M increase.
  • Oppenheimer & Co's biggest Q2 2016 reduction was Energy Transfer Partners L.p., cutting an estimated $6.24M.
  • Oppenheimer & Co fully exited Wolfspeed in Q2 2016, selling an estimated $4.45M.
  • Oppenheimer & Co's ten largest holdings make up 15% of its $3.35B portfolio in Q2 2016.
  • Oppenheimer & Co opened 104 new positions and closed 129 in Q2 2016.
  • Oppenheimer & Co's portfolio value rose 1.9% quarter-over-quarter to $3.35B.

Based on Oppenheimer & Co's 13F filing for Q2 2016, filed 8 Aug 2016.